CULLINAN Trademark

Trademark Overview


On Thursday, October 6, 2016, a trademark application was filed for CULLINAN with the United States Patent and Trademark Office. The USPTO has given the CULLINAN trademark a serial number of 87194610. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2019. This trademark is owned by Cullinan Pharmaceuticals, LLC. The CULLINAN trademark is filed in the Insurance & Financial Services category with the following description:

Advice relating to investments; Brokerage services for capital investments; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Business equity research; Business finance procurement services; Capital investment; Capital investment consulting; Capital investment services; Consultancy of capital investment; Debt management consultation; Equity capital investment; Facilitating and arranging for the financing of start up ventures in the field of oncology, pharmaceuticals, and therapeutics; Fiduciary representatives; Financial advice; Financial advice and consultancy services; Financial advisory and consultancy services; Financial and investment services, namely, asset and investment acquisition, consultation, advisory and development; Financial consultancy; Financial consultancy services in the area of healthcare; Financial consultation; Financial consultation in the field of oncology and therapeutic products for ...
cullinan

General Information


Serial Number87194610
Word MarkCULLINAN
Filing DateThursday, October 6, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements


Goods and ServicesAdvice relating to investments; Brokerage services for capital investments; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Business equity research; Business finance procurement services; Capital investment; Capital investment consulting; Capital investment services; Consultancy of capital investment; Debt management consultation; Equity capital investment; Facilitating and arranging for the financing of start up ventures in the field of oncology, pharmaceuticals, and therapeutics; Fiduciary representatives; Financial advice; Financial advice and consultancy services; Financial advisory and consultancy services; Financial and investment services, namely, asset and investment acquisition, consultation, advisory and development; Financial consultancy; Financial consultancy services in the area of healthcare; Financial consultation; Financial consultation in the field of oncology and therapeutic products for the pharma industry; Financial consulting; Financial due diligence; Financial investment in the field of oncology and therapeutic products for the pharma industry; Financial loan consultation; Financial portfolio management; Financial research and information services; Financial restructuring services; Financial services in the nature of an investment security; Financial services, namely, raising debt and equity capital for others; Fundraising for others for the purpose of purchasing companies; Funds investment; Incubation services, namely, providing financing to freelancers, start-ups, existing businesses and non-profits; Incubation services, namely, rental of office space to freelancers, start-ups, existing businesses and non-profits; Information, advisory, consultancy and research services relating to finance and investments; Investment advisory services; Investment consultancy; Investment consultation; Investment management; Investment management in the fields of oncology and therapeutic products for the pharma industry; Investment management services in the field of acquiring joint ventures; Investment services, namely, asset acquisition, consultation, development and management services; Management of a capital investment fund; Management of private equity funds; Mutual funds and capital investment; Private equity consultant services; Private equity fund investment services; Providing financial information; Providing fundraising services for others via a global computer network; Providing investors with financial information; Providing loans secured by commercial paper; Providing venture capital, development capital, private equity and investment funding; Providing working capital; Providing working capital financing to small businesses and small business owners; Provision of financial information; Public equity investment management; Strategic corporate financial advisory services; Strategic financial advisory services; Venture capital advisory services; Venture capital financing; Venture capital fund management; Venture capital funding services to emerging and start-up companies; Venture capital services, namely, providing financing to emerging and start-up companies

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2016
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCULLINAN ONCOLOGY, LLC
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameCullinan Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameCullinan Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, July 8, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 8, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 2 GRANTED
Wednesday, December 5, 2018EXTENSION 2 FILED
Monday, December 17, 2018NOTICE OF REVIVAL - E-MAILED
Sunday, December 16, 2018EXTENSION RECEIVED WITH TEAS PETITION
Sunday, December 16, 2018PETITION TO REVIVE-GRANTED
Sunday, December 16, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 10, 2018EXTENSION 1 GRANTED
Tuesday, June 5, 2018EXTENSION 1 FILED
Monday, September 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 1, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 23, 2018NOTICE OF REVIVAL - E-MAILED
Sunday, July 22, 2018EXTENSION RECEIVED WITH TEAS PETITION
Sunday, July 22, 2018PETITION TO REVIVE-GRANTED
Sunday, July 22, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, July 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2017ASSIGNED TO LIE
Wednesday, August 16, 2017NOTICE OF REVIVAL - E-MAILED
Tuesday, August 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 15, 2017PETITION TO REVIVE-GRANTED
Tuesday, August 15, 2017TEAS PETITION TO REVIVE RECEIVED
Wednesday, January 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION WRITTEN
Tuesday, January 17, 2017ASSIGNED TO EXAMINER
Tuesday, October 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 10, 2016NEW APPLICATION ENTERED IN TRAM